Noel Foundations
Committed to society
The Noel commitment to society is reaffirmed through its two foundations: the Albert Bosch Foundation and the Maria Rosa Sans Foundation. Each one aims to contribute to a better world.
Albert Bosch Foundation
In 2004, Noel Alimentaria founded the Albert Bosch Foundation in honour of Albert Bosch Sala, who was a great promoter of the company and the father of Anna Bosch, the current Managing Director of Noel and President of the Foundation.
The Albert Bosch Foundations arose from our belief in returning to society part of what we have received and contributing to people’s well-being, through medical research initiatives. The Foundation particularly focusses on promoting research and the search for medical, biomedical and surgical solutions for children’s diseases, specifically childhood cancer, with close collaboration with the Vall d’Hebron Hospital in Barcelona.
Maria Rosa Sans Foundation
The Maria Rosa Sans Foundation was founded in 2018 with the main aim of promoting equal opportunities and favouring people’s growth and development through training and the promotion of personal autonomy. The foundation is named after Maria Rosa Sans, a committed rural teacher with a great social vocation who is also the mother of Joan Boix, the current Chairman of Noel.
This initiative is dedicated to promoting young talent in La Garrotxa through grants to students with academic abilities, but with limited economic resources, so they may access university education.
Eudald Morera Foundation
Fruit of the initiative of Royalverd and Noel, in 2022 the Vallviva Foundation, now the Eudald Morera Foundation, was founded. Its aim is to promote actions to guarantee people’s physical, psychological and social well-being, particularly those affected by oncological diseases.
Among other activities, the foundation promotes the Vallviva Festival, a charity event whose profits go to the Vall d’Hebron Hospital Campus for research into cancer-related diseases and the improvement of the quality of life of cancer patients.